Back to search
Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is planned to include 80 patients with HRD positive HER2-negative advanced breast cancer to receive fluzoparib alone or fluzoparib combined with camr…
This is a Phase III clinical trial for patients with a specific type of advanced breast cancer that is HER2-negative and has a biomarker called "Homologous Reco…